Skip to content
healthcare.dev

Topotecan hydrochloride

NDC 45963-615, Topotecan hydrochloride, injection, powder, lyophilized, for solution, from Actavis Pharma, Inc..

Product NDC
45963-615
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090620
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45963-615 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPOTECAN HYDROCHLORIDE4 mg/4mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
45963-615-56459630615561 VIAL in 1 CARTON (45963-615-56) / 4 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/996430c0-ee26-4ed9-82b8-a8b645becba6
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=45963-615

Use it

Look up 45963-615 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45963-615 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45963-615. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.